Vaginal health takes center stage as Seed Health, a microbiome science company, unveils its latest innovation: VS-01 Vaginal Synbiotic. With a focus on redefining vaginal care, VS-01 represents a new vaginal synbiotic clinically validated to establish and sustain an optimal vaginal microbiome. Developed in collaboration with renowned vaginal microbiome scientist Dr. Jacques Ravel, VS-01 aims to address the critical role of the…
Seed Health has launched CODA, a computational biology platform aimed at discovering and developing precision probiotics and microbiome-directed interventions. Powered by the Human Phenotype Project, the world’s most extensive multi-omics dataset, CODA focuses on advancing research in metabolic health, brain health, menopause, and longevity. CODA integrates over three million phenotypic data points from more than 13,000 individuals across 40,000 cumulative subject years.…
Freya Biosciences, a biotech company specializing in women’s health, has released positive topline results from the Phase 1 clinical trial of FB101, their vaginal microbial immunotherapeutic. The trial focused on addressing asymptomatic vaginal dysbiosis, a common condition in women undergoing infertility treatments. The findings show promise for improving fertility outcomes, particularly in in vitro fertilization (IVF) procedures. Freya Biosciences, headquartered in Copenhagen,…
Biotech company Concerto Biosciences has announced a new strategic initiative to combat recurrent vaginal yeast infections. The company is dedicated to developing a novel microbial product, Ensemble No.3 (ENS-003), specifically targeting vulvovaginal candidiasis (VVC). This prevalent condition affects approximately 75% of women at some point in their lives and poses significant challenges due to limited protection provided by existing antifungal treatments. “All…
Vaginal discomfort is one of the leading reasons women seek healthcare advice, and over 90% of these cases can be attributed to imbalances in the vaginal microbiome. Yet current standards for vaginal health testing and care don’t take into account the entire vaginal microbiome. Instead, vaginal healthcare is underpinned by overly simplistic methods like microscopy and brute-force antibiotics. Evvy, a female-founded startup on a…
Vaginal discomfort is one of the leading reasons women seek healthcare advice, and over 90% of these cases can be attributed to imbalances in the vaginal microbiome. Despite the high prevalence of vaginitis and the rapid adoption of DNA testing into many other branches of medicine, vaginitis testing remains limited. Most clinicians diagnose based on the Amsel score criteria, which is oftentimes unreliable and subjective as…
Biom Pharmaceuticals, a leading microbiome research company and creator of femtech brand VagiBiom, has just launched Vee, a female-focused mobile health app that supports women’s health at each stage of the female journey. Backed by science, Vee offers reliable resources to help women maintain peak health at each phase of womanhood. From tracking one’s period, to planning a pregnancy, to making menopause a time of…
